AlphaCrest Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,984
| Closed | -$2.72M | – | 362 |
|
|
2022
Q3 | $2.72M | Buy |
5,984
+1,357
| +29% | +$616K | 0.17% | 125 |
|
|
2022
Q2 | $2.23M | Buy |
4,627
+3,917
| +552% | +$1.89M | 0.11% | 271 |
|
|
2022
Q1 | $349K | Sell |
710
-3,006
| -81% | -$1.48M | 0.02% | 1051 |
|
|
2021
Q4 | $1.72M | Buy |
3,716
+1,163
| +46% | +$539K | 0.06% | 509 |
|
|
2021
Q3 | $952K | Sell |
2,553
-8,913
| -78% | -$3.32M | 0.05% | 637 |
|
|
2021
Q2 | $4.38M | Buy |
11,466
+7,567
| +194% | +$2.89M | 0.19% | 132 |
|
|
2021
Q1 | $1.4M | Buy |
3,899
+700
| +22% | +$251K | 0.08% | 378 |
|
|
2020
Q4 | $1.03M | Sell |
3,199
-8,629
| -73% | -$2.77M | 0.09% | 309 |
|
|
2020
Q3 | $3.18M | Buy |
11,828
+2,230
| +23% | +$599K | 0.35% | 32 |
|
|
2020
Q2 | $2.52M | Sell |
9,598
-7,601
| -44% | -$2M | 0.42% | 25 |
|
|
2020
Q1 | $3.91M | Buy |
17,199
+4,031
| +31% | +$915K | 0.47% | 6 |
|
|
2019
Q4 | $3.98M | Sell |
13,168
-9,750
| -43% | -$2.94M | 0.33% | 36 |
|
|
2019
Q3 | $5.5M | Buy |
22,918
+13,434
| +142% | +$3.23M | 0.33% | 24 |
|
|
2019
Q2 | $2.68M | Sell |
9,484
-7,037
| -43% | -$1.99M | 0.23% | 90 |
|
|
2019
Q1 | $4.74M | Buy |
16,521
+13,921
| +535% | +$3.99M | 0.72% | 9 |
|
|
2018
Q4 | $683K | Buy |
+2,600
| New | +$683K | 0.2% | 143 |
|